Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Novozymes price target raised to DKK 320 from DKK 310 at Deutsche Bank » 13:13
07/02/20
07/02
13:13
07/02/20
13:13
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Deutsche Bank analyst Virginie Boucher-Ferte raised the firm's price target on Novozymes to DKK 320 from DKK 310 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

05/12/20 Credit Suisse
Novozymes downgraded to Underperform from Outperform at Credit Suisse
04/01/20 Goldman Sachs
Novozymes downgraded to Sell from Buy at Goldman Sachs
03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
Over a week ago
Conference/Events
Healthcare Financial Management Association to hold a virtual conference » 08:56
06/24/20
06/24
08:56
06/24/20
08:56
MTBC

MTBC

$8.50 /

-0.26 (-2.97%)

, NVZMY

Novozymes

$0.00 /

+ (+0.00%)

, NVS

Novartis

$90.49 /

-0.09 (-0.10%)

, NVAX

Novavax

$69.66 /

+3.72 (+5.64%)

, MRK

Merck

$77.11 /

+0.4 (+0.52%)

, LOGI

Logitech

$62.73 /

-0.32 (-0.51%)

, REGN

Regeneron

$628.72 /

+0.81 (+0.13%)

, RDY

Dr. Reddy's

$54.33 /

+1.04 (+1.95%)

, FREQ

Frequency Therapeutics

$22.68 /

-0.47 (-2.03%)

, RCKT

Rocket Pharmaceuticals

$22.80 /

+0.275 (+1.22%)

, TRVI

Trevi Therapeutics

$5.71 /

+0.26 (+4.77%)

, CSU

Capital Senior Living

$0.76 /

-0.037 (-4.64%)

, NVO

Novo Nordisk

$67.93 /

-0.005 (-0.01%)

HFMA 2020 Digital Annual…

HFMA 2020 Digital Annual Conference will be held on June 24. Webcast Link

ShowHide Related Items >><<
TRVI Trevi Therapeutics
$5.71 /

+0.26 (+4.77%)

REGN Regeneron
$628.72 /

+0.81 (+0.13%)

RDY Dr. Reddy's
$54.33 /

+1.04 (+1.95%)

RCKT Rocket Pharmaceuticals
$22.80 /

+0.275 (+1.22%)

NVS Novartis
$90.49 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.93 /

-0.005 (-0.01%)

NVAX Novavax
$69.66 /

+3.72 (+5.64%)

MTBC MTBC
$8.50 /

-0.26 (-2.97%)

MRK Merck
$77.11 /

+0.4 (+0.52%)

LOGI Logitech
$62.73 /

-0.32 (-0.51%)

FREQ Frequency Therapeutics
$22.68 /

-0.47 (-2.03%)

CSU Capital Senior Living
$0.76 /

-0.037 (-4.64%)

MTBC MTBC
$8.50 /

-0.26 (-2.97%)

06/22/20 H.C. Wainwright
MTBC upgraded to Buy from Neutral at H.C. Wainwright
06/02/20 Ladenburg
MTBC initiated with a Buy at Ladenburg
03/03/20
LD Micro to hold a virtual conference
03/02/20
Fly Intel: Top five analyst downgrades
NVZMY Novozymes
$0.00 /

+ (+0.00%)

05/12/20 Credit Suisse
Novozymes downgraded to Underperform from Outperform at Credit Suisse
04/01/20 Goldman Sachs
Novozymes downgraded to Sell from Buy at Goldman Sachs
03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
NVS Novartis
$90.49 /

-0.09 (-0.10%)

06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/16/20 Guggenheim
Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown
06/15/20
Fly Intel: Top five analyst upgrades
06/15/20 Citi
Novartis upgraded to Buy from Neutral at Citi
NVAX Novavax
$69.66 /

+3.72 (+5.64%)

06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
MRK Merck
$77.11 /

+0.4 (+0.52%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/23/20 Morgan Stanley
Merck's COVID-19 antiviral candidate underappreciated, says Morgan Stanley
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/12/20 Wolfe Research
Merck downgraded to Peer Perform from Outperform at Wolfe Research
LOGI Logitech
$62.73 /

-0.32 (-0.51%)

06/24/20 Wedbush
Logitech downgraded to Neutral at Wedbush with limited multiple expansion ahead
06/24/20 Wedbush
Logitech downgraded to Neutral from Outperform at Wedbush
06/04/20 DA Davidson
Logitech price target raised to $70 from $64 at DA Davidson
05/21/20
Fly Intel: Top five analyst downgrades
REGN Regeneron
$628.72 /

+0.81 (+0.13%)

06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
06/15/20 Piper Sandler
Piper says 'meaningfully above-consensus estimates' for Dupixent are right
RDY Dr. Reddy's
$54.33 /

+1.04 (+1.95%)

06/17/20 SVB Leerink
Amarin doubling down on appeal after settlement with Apotex, says SVB Leerink
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
04/21/20 Nomura Instinet
Dr. Reddy's price target raised to INR 4,426 from INR 3,684
03/31/20 Goldman Sachs
Goldman downgrades Amarin, cuts target to $4 from $27 after patent ruling
FREQ Frequency Therapeutics
$22.68 /

-0.47 (-2.03%)

05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
05/18/20 JPMorgan
Frequency Therapeutics downgraded to Neutral from Overweight at JPMorgan
10/28/19 JPMorgan
Frequency Therapeutics initiated with an Overweight at JPMorgan
10/28/19 Cowen
Frequency Therapeutics initiated with an Outperform at Cowen
RCKT Rocket Pharmaceuticals
$22.80 /

+0.275 (+1.22%)

05/13/20 Piper Sandler
Rocket Pharmaceuticals programs look even more promising, says Piper Sandler
03/05/20 Piper Sandler
Piper sees 'substantial value' for Rocket from numerous trial readouts
12/09/19 Oppenheimer
Rocket Pharmaceuticals price target raised to $42 from $36 at Oppenheimer
12/06/19 Baird
Rocket Pharmaceuticals elevated to Fresh Pick, target raised to $41 at Baird
TRVI Trevi Therapeutics
$5.71 /

+0.26 (+4.77%)

CSU Capital Senior Living
$0.76 /

-0.037 (-4.64%)

09/03/19 Barclays
Capital Senior Living initiated with an Underweight at Barclays
NVO Novo Nordisk
$67.93 /

-0.005 (-0.01%)

06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
05/11/20
Fly Intel: Top five analyst downgrades
TRVI Trevi Therapeutics
$5.71 /

+0.26 (+4.77%)

REGN Regeneron
$628.72 /

+0.81 (+0.13%)

RDY Dr. Reddy's
$54.33 /

+1.04 (+1.95%)

RCKT Rocket Pharmaceuticals
$22.80 /

+0.275 (+1.22%)

NVS Novartis
$90.49 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.93 /

-0.005 (-0.01%)

NVAX Novavax
$69.66 /

+3.72 (+5.64%)

MTBC MTBC
$8.50 /

-0.26 (-2.97%)

MRK Merck
$77.11 /

+0.4 (+0.52%)

LOGI Logitech
$62.73 /

-0.32 (-0.51%)

FREQ Frequency Therapeutics
$22.68 /

-0.47 (-2.03%)

CSU Capital Senior Living
$0.76 /

-0.037 (-4.64%)

REGN Regeneron
$628.72 /

+0.81 (+0.13%)

NVS Novartis
$90.49 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.93 /

-0.005 (-0.01%)

NVAX Novavax
$69.66 /

+3.72 (+5.64%)

MRK Merck
$77.11 /

+0.4 (+0.52%)

REGN Regeneron
$628.72 /

+0.81 (+0.13%)

RDY Dr. Reddy's
$54.33 /

+1.04 (+1.95%)

NVS Novartis
$90.49 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.93 /

-0.005 (-0.01%)

NVAX Novavax
$69.66 /

+3.72 (+5.64%)

MRK Merck
$77.11 /

+0.4 (+0.52%)

LOGI Logitech
$62.73 /

-0.32 (-0.51%)

REGN Regeneron
$628.72 /

+0.81 (+0.13%)

NVS Novartis
$90.49 /

-0.09 (-0.10%)

NVAX Novavax
$69.66 /

+3.72 (+5.64%)

MRK Merck
$77.11 /

+0.4 (+0.52%)

LOGI Logitech
$62.73 /

-0.32 (-0.51%)

FREQ Frequency Therapeutics
$22.68 /

-0.47 (-2.03%)

Over a month ago
Conference/Events
Berenberg to hold a virual conference » 08:18
05/20/20
05/20
08:18
05/20/20
08:18
PHG

Philips

$43.07 /

-0.18 (-0.42%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BNTX

BioNTech

$50.59 /

-9.67 (-16.05%)

, BAESY

BAE Systems

$0.00 /

+ (+0.00%)

, WNS

WNS Holdings

$43.17 /

+0.41 (+0.96%)

, IEX

Idex Corp.

$151.37 /

-3.335 (-2.16%)

, BASFY

BASF

$0.00 /

+ (+0.00%)

, VEOEY

Veolia Environment

$0.00 /

+ (+0.00%)

, ZBRA

Zebra Technologies

$240.54 /

+4.36 (+1.85%)

, NVZMY

Novozymes

$0.00 /

+ (+0.00%)

, BUD

AB InBev

$41.27 /

-1.83 (-4.25%)

, IFF

IFF

$128.95 /

-3.025 (-2.29%)

Berenberg Virtual…

Berenberg Virtual Conference USA 2020 will be held on May 18-20.

ShowHide Related Items >><<
ZBRA Zebra Technologies
$240.54 /

+4.36 (+1.85%)

WNS WNS Holdings
$43.17 /

+0.41 (+0.96%)

PHG Philips
$43.07 /

-0.18 (-0.42%)

NVZMY Novozymes
$0.00 /

+ (+0.00%)

IFF IFF
$128.95 /

-3.025 (-2.29%)

IEX Idex Corp.
$151.37 /

-3.335 (-2.16%)

BUD AB InBev
$41.27 /

-1.83 (-4.25%)

BNTX BioNTech
$50.59 /

-9.67 (-16.05%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BASFY BASF
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

PHG Philips
$43.07 /

-0.18 (-0.42%)

04/22/20 Morgan Stanley
Philips price target lowered to EUR 45 from EUR 50 at Morgan Stanley
04/21/20 JPMorgan
Philips price target raised to EUR 36.80 from EUR 33.90 at JPMorgan
04/07/20 JPMorgan
Philips price target lowered to EUR 33.90 from EUR 43.10 at JPMorgan
03/24/20 DZ Bank
Philips upgraded to Buy from Hold at DZ Bank
BAYRY Bayer
$0.00 /

+ (+0.00%)

05/11/20 Wedbush
MyoKardia price target raised to $127 from $90 at Wedbush
04/22/20 Morgan Stanley
Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley
03/13/20 Goldman Sachs
Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs
03/11/20 Deutsche Bank
Deutsche Bank names Bayer as 'Catalyst Call' buy idea
BNTX BioNTech
$50.59 /

-9.67 (-16.05%)

05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
04/13/20 H.C. Wainwright
BioNTech price target raised to $48 from $30 at H.C. Wainwright
BAESY BAE Systems
$0.00 /

+ (+0.00%)

05/18/20 UBS
BAE Systems price target lowered to 511 GBp from 700 GBp at UBS
04/29/20 JPMorgan
BAE Systems price target lowered to 765 GBp from 775 GBp at JPMorgan
04/29/20 JPMorgan
BAE Systems shares offer 50% upside potential, says JPMorgan
04/27/20 Morgan Stanley
BAE Systems upgraded to Overweight from Equal Weight at Morgan Stanley
WNS WNS Holdings
$43.17 /

+0.41 (+0.96%)

04/24/20 Deutsche Bank
WNS Holdings price target lowered to $56 from $81 at Deutsche Bank
04/23/20 Needham
WNS Holdings downgraded to Buy from Strong Buy at Needham
04/21/20 Cowen
WNS Holdings price target lowered to $57 from $77 at Cowen
04/17/20 Wells Fargo
WNS Holdings downgraded to Equal Weight from Overweight at Wells Fargo
IEX Idex Corp.
$151.37 /

-3.335 (-2.16%)

04/27/20 Wells Fargo
Idex Corp. price target raised to $178 from $160 at Wells Fargo
04/08/20 Janney Montgomery Scott
Janney Montgomery Scott downgrades Idex to Neutral, sees 'reasonable' valuation
04/08/20 Janney Montgomery Scott
Idex Corp. downgraded to Neutral from Buy at Janney Montgomery Scott
03/31/20 Cowen
Idex Corp. upgraded to Outperform at Cowen
BASFY BASF
$0.00 /

+ (+0.00%)

05/12/20 DZ Bank
BASF downgraded to Hold from Buy at DZ Bank
03/30/20 Morgan Stanley
BASF price target lowered to EUR 53 from EUR 63 at Morgan Stanley
03/24/20 JPMorgan
BASF price target lowered to EUR 39 from EUR 55 at JPMorgan
03/13/20 JPMorgan
BASF price target lowered to EUR 55 from EUR 65 at JPMorgan
VEOEY Veolia Environment
$0.00 /

+ (+0.00%)

04/24/20 Deutsche Bank
Veolia price target lowered to EUR 15.50 from EUR 16.50 at Deutsche Bank
04/14/20 Societe Generale
Veolia price target lowered to EUR 23.50 from EUR 28.50 at Societe Generale
03/27/20 BofA
Veolia Environment downgraded to Underperform from Neutral at BofA
03/23/20 Goldman Sachs
Veolia price target lowered to EUR 22.70 from EUR 27.20 at Goldman Sachs
ZBRA Zebra Technologies
$240.54 /

+4.36 (+1.85%)

05/04/20 Imperial Capital
Zebra Technologies price target lowered to $250 from $265 at Imperial Capital
04/30/20
Fly Intel: Top five analyst downgrades
04/30/20 Northcoast
Northcoast downgrades Zebra Technologies to Neutral after 'too fast' move higher
04/30/20 Northcoast
Zebra Technologies downgraded to Neutral from Buy at Northcoast
NVZMY Novozymes
$0.00 /

+ (+0.00%)

05/12/20 Credit Suisse
Novozymes downgraded to Underperform from Outperform at Credit Suisse
04/01/20 Goldman Sachs
Novozymes downgraded to Sell from Buy at Goldman Sachs
03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
BUD AB InBev
$41.27 /

-1.83 (-4.25%)

05/20/20 JPMorgan
AB InBev upgraded to Neutral from Underweight at JPMorgan
05/13/20 Morgan Stanley
AB InBev price target lowered to EUR 39 from EUR 40 at Morgan Stanley
04/20/20 Morgan Stanley
AB InBev downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/20 Evercore ISI
Beer production not resuming in Mexico, says Evercore ISI
IFF IFF
$128.95 /

-3.025 (-2.29%)

04/29/20 Wells Fargo
IFF upgraded to Overweight from Equal Weight at Wells Fargo
04/20/20 JPMorgan
JPMorgan upgrades DuPont with 45% upside potential by year-end
04/20/20 JPMorgan
DuPont upgraded to Overweight from Neutral at JPMorgan
04/06/20 Exane BNP Paribas
IFF upgraded to Neutral from Underperform at Exane BNP Paribas
ZBRA Zebra Technologies
$240.54 /

+4.36 (+1.85%)

WNS WNS Holdings
$43.17 /

+0.41 (+0.96%)

PHG Philips
$43.07 /

-0.18 (-0.42%)

IFF IFF
$128.95 /

-3.025 (-2.29%)

IEX Idex Corp.
$151.37 /

-3.335 (-2.16%)

BUD AB InBev
$41.27 /

-1.83 (-4.25%)

BNTX BioNTech
$50.59 /

-9.67 (-16.05%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

PHG Philips
$43.07 /

-0.18 (-0.42%)

IFF IFF
$128.95 /

-3.025 (-2.29%)

BUD AB InBev
$41.27 /

-1.83 (-4.25%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BASFY BASF
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

PHG Philips
$43.07 /

-0.18 (-0.42%)

IFF IFF
$128.95 /

-3.025 (-2.29%)

BUD AB InBev
$41.27 /

-1.83 (-4.25%)

BNTX BioNTech
$50.59 /

-9.67 (-16.05%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BASFY BASF
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

IFF IFF
$128.95 /

-3.025 (-2.29%)

BUD AB InBev
$41.27 /

-1.83 (-4.25%)

BNTX BioNTech
$50.59 /

-9.67 (-16.05%)

Downgrade
Novozymes downgraded to Underperform from Outperform at Credit Suisse » 06:55
05/12/20
05/12
06:55
05/12/20
06:55
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Credit Suisse analyst Samuel Perry double downgraded Novozymes to Underperform from Outperform with a price target of DKK 302, down from DKK 340. The analyst believes BioEnergy end markets will be an overhang on organic growth and that the company's medium term competitive position will come under pressure due to retained lower oil prices and crush spreads.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

NVZMY Novozymes
$0.00 /

+ (+0.00%)

04/01/20 Goldman Sachs
Novozymes downgraded to Sell from Buy at Goldman Sachs
03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
Over a quarter ago
Downgrade
Novozymes downgraded to Sell from Buy at Goldman Sachs » 05:23
04/01/20
04/01
05:23
04/01/20
05:23
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Theodora Lee Joseph double downgraded Novozymes to Sell from Buy with a price target of DKK 300, down from DKK 400. The analyst expects the negative momentum in the companny;s growth to accelerate in the first half of 2020, owing to "unprecedented changes" in the macro environment from COVID-19.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
Recommendations
Goldman Sachs to hold a conference » 04:55
03/13/20
03/13
04:55
03/13/20
04:55
BASFY

BASF

$0.00 /

+ (+0.00%)

, COVTY

Covestro

$0.00 /

+ (+0.00%)

, EVKIF

Evonik

$0.00 /

+ (+0.00%)

, JMPLY

Johnson Matthey

$0.00 /

+ (+0.00%)

, KPLUF

K+S

$0.00 /

+ (+0.00%)

, LNXSF

Lanxess

$0.00 /

+ (+0.00%)

, NVZMY

Novozymes

$0.00 /

+ (+0.00%)

, SOLVY

Solvay

$0.00 /

+ (+0.00%)

9th Annual European…

9th Annual European Chemicals Conference to be held in London, England on March 12-13.

ShowHide Related Items >><<
BASFY BASF
$0.00 /

+ (+0.00%)

02/05/20 Berenberg
BASF downgraded to Hold from Buy at Berenberg
01/30/20 Societe Generale
BASF upgraded to Buy from Hold at Societe Generale
09/10/19 Citi
BASF downgraded to Neutral from Buy at Citi
COVTY Covestro
$0.00 /

+ (+0.00%)

03/03/20 Berenberg
Berenberg upgrades Covestro to Hold with 'worst-case' priced in
03/03/20 Berenberg
Covestro upgraded to Hold from Sell at Berenberg
02/07/20 Citi
Covestro upgraded to Buy from Sell at Citi
02/05/20 Berenberg
As Tesla rises, Berenberg downgrades BASF to Hold, cuts Covestro to Sell
EVKIF Evonik
$0.00 /

+ (+0.00%)

03/12/20 Berenberg
Evonik price target lowered to EUR 27 from EUR 30 at Berenberg
03/11/20 JPMorgan
JPMorgan backs Overweight on Evonik after management meeting
03/09/20 Barclays
Evonik price target lowered to EUR 28.50 from EUR 29 at Barclays
03/06/20 UBS
Evonik price target lowered to EUR 21 from EUR 22 at UBS
JMPLY Johnson Matthey
$0.00 /

+ (+0.00%)

03/05/20 Berenberg
Johnson Matthey price target lowered to 3,300 GBp from 3,600 GBp at Berenberg
11/28/19 JPMorgan
Johnson Matthey downgraded to Underweight from Neutral at JPMorgan
09/17/19 Barclays
Johnson Matthey downgraded to Equal Weight from Overweight at Barclays
KPLUF K+S
$0.00 /

+ (+0.00%)

03/12/20 JPMorgan
JPMorgan backs Underweight on K+S after Q4 preannouncement
03/12/20 Deutsche Bank
K+S price target lowered to EUR 9 from EUR 10 at Deutsche Bank
02/27/20 Berenberg
K+S downgraded to Sell from Hold at Berenberg
02/20/20 Credit Suisse
K+S downgraded to Underperform from Neutral at Credit Suisse
LNXSF Lanxess
$0.00 /

+ (+0.00%)

03/12/20 JPMorgan
JPMorgan backs Neutral on Lanxess after 'mixed' Q4 results
03/12/20 Deutsche Bank
Lanxess price target lowered to EUR 70 from EUR 73 at Deutsche Bank
03/12/20 Credit Suisse
Lanxess price target lowered to EUR 52 from EUR 57 at Credit Suisse
03/11/20 Deutsche Bank
Deutsche Bank backs Buy on Lanxess after share buyback announcement
NVZMY Novozymes
$0.00 /

+ (+0.00%)

01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
11/20/19 Citi
Novozymes upgraded to Buy from Neutral at Citi
SOLVY Solvay
$0.00 /

+ (+0.00%)

12/12/19 Exane BNP Paribas
Solvay downgraded to Underperform from Neutral at Exane BNP Paribas
12/12/19 JPMorgan
Solvay upgraded to Overweight from Neutral at JPMorgan
11/12/19 Berenberg
Solvay upgraded to Buy from Hold at Berenberg
Conference/Events
Credit Suisse to hold a conference » 08:25
03/12/20
03/12
08:25
03/12/20
08:25
BASFY

BASF

$0.00 /

+ (+0.00%)

, COVTY

Covestro

$0.00 /

+ (+0.00%)

, EVKIF

Evonik

$0.00 /

+ (+0.00%)

, JMPLY

Johnson Matthey

$0.00 /

+ (+0.00%)

, KPLUF

K+S

$0.00 /

+ (+0.00%)

, LNXSF

Lanxess

$0.00 /

+ (+0.00%)

, NVZMY

Novozymes

$0.00 /

+ (+0.00%)

, SOLVY

Solvay

$0.00 /

+ (+0.00%)

9th Annual European…

9th Annual European Chemicals Conference to be held in London, England on March 12-13.

ShowHide Related Items >><<
BASFY BASF
$0.00 /

+ (+0.00%)

02/05/20 Berenberg
As Tesla rises, Berenberg downgrades BASF to Hold, cuts Covestro to Sell
02/05/20 Berenberg
BASF downgraded to Hold from Buy at Berenberg
01/30/20 Societe Generale
BASF upgraded to Buy from Hold at Societe Generale
09/10/19 Citi
BASF downgraded to Neutral from Buy at Citi
COVTY Covestro
$0.00 /

+ (+0.00%)

03/03/20 Berenberg
Berenberg upgrades Covestro to Hold with 'worst-case' priced in
03/03/20 Berenberg
Covestro upgraded to Hold from Sell at Berenberg
02/07/20 Citi
Covestro upgraded to Buy from Sell at Citi
EVKIF Evonik
$0.00 /

+ (+0.00%)

03/11/20 JPMorgan
JPMorgan backs Overweight on Evonik after management meeting
03/09/20 Barclays
Evonik price target lowered to EUR 28.50 from EUR 29 at Barclays
03/06/20 UBS
Evonik price target lowered to EUR 21 from EUR 22 at UBS
03/05/20 Exane BNP Paribas
Evonik upgraded to Neutral from Underperform at Exane BNP Paribas
JMPLY Johnson Matthey
$0.00 /

+ (+0.00%)

03/05/20 Berenberg
Johnson Matthey price target lowered to 3,300 GBp from 3,600 GBp at Berenberg
11/28/19 JPMorgan
Johnson Matthey downgraded to Underweight from Neutral at JPMorgan
09/17/19 Barclays
Johnson Matthey downgraded to Equal Weight from Overweight at Barclays
KPLUF K+S
$0.00 /

+ (+0.00%)

02/27/20 Berenberg
K+S downgraded to Sell from Hold at Berenberg
02/20/20 Credit Suisse
K+S downgraded to Underperform from Neutral at Credit Suisse
01/29/20 Pareto
K+S upgraded to Buy from Hold at Pareto
10/14/19 UBS
K+S downgraded to Neutral from Buy at UBS
LNXSF Lanxess
$0.00 /

+ (+0.00%)

03/11/20 Deutsche Bank
Deutsche Bank backs Buy on Lanxess after share buyback announcement
01/30/20 Berenberg
Lanxess upgraded to Buy from Hold at Berenberg
10/22/19 JPMorgan
Lanxess downgraded to Neutral from Overweight at JPMorgan
10/07/19 Goldman Sachs
Lanxess downgraded to Neutral from Buy at Goldman Sachs
NVZMY Novozymes
$0.00 /

+ (+0.00%)

01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
11/20/19 Citi
Novozymes upgraded to Buy from Neutral at Citi
SOLVY Solvay
$0.00 /

+ (+0.00%)

12/12/19 Exane BNP Paribas
Solvay downgraded to Underperform from Neutral at Exane BNP Paribas
12/12/19 JPMorgan
Solvay upgraded to Overweight from Neutral at JPMorgan
11/12/19 Berenberg
Solvay upgraded to Buy from Hold at Berenberg
Conference/Events
Novozymes management to meet with Jefferies » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Meeting to be held in New…

Meeting to be held in New York on January 28 hosted by Jefferies.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
11/20/19 Citi
Novozymes upgraded to Buy from Neutral at Citi
Conference/Events
Novozymes management to meet with Jefferies » 14:06
01/27/20
01/27
14:06
01/27/20
14:06
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Meeting to be held in New…

Meeting to be held in New York on January 28 hosted by Jefferies.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
11/20/19 Citi
Novozymes upgraded to Buy from Neutral at Citi
Downgrade
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas » 05:41
01/14/20
01/14
05:41
01/14/20
05:41
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Nicola Tang downgraded Novozymes to Neutral from Outperform with a NOK 350 price target.

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

01/07/20 Goldman Sachs
Novozymes initiated with a Buy at Goldman Sachs
12/17/19 Berenberg
Novozymes downgraded to Hold from Buy at Berenberg
11/20/19 Citi
Novozymes upgraded to Buy from Neutral at Citi
09/30/19 JPMorgan
Novozymes downgraded to Underweight from Neutral at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.